Amachiza amaninzi ekujoliswe kuwo athandwa kakhulu yimali. Iinkampani zasekhaya zonyango zigxininiswe kuphando kunye nophuhliso lwamachiza ekujoliswe kuwo afana ne-EGFR, PD-1/PD-L1, HER2, CD19, kunye ne-VEGFR2. Phakathi kwabo, i-60 yi-EFGR yophando kunye neenkampani zophuhliso, i-33 yi-HER2, kunye ne-155 yi-PD-1 / PD-L (kubandakanywa nesigaba seKliniki kunye nokuthengisa).
Ukuphuhliswa kwamachiza anenjongo efanayo kukhokelele kwimeko apho kuphela iinkampani ezimbalwa zinokuhlangabezana nemfuno yemarike, kodwa uninzi lweenkampani ziyakhuphisana. I-homogeneity yamachiza iyabonakala, ukusebenza ngempumelelo akuphucukanga kakhulu, kwaye Izibonelelo zeklinikhi ezilinganiselwe ngokwendalo ziya kubangela inkqubela ecothayo ekubhaliseni izigulane namanye amachiza achasene nomhlaza.
Phakathi kwazo, inkunzi yadlala indima ekuphembeleleni amadangatye. "Ukuma emagxeni eengxilimbela kuhlala kulula ukuphumelela." U-Cheng Jie ukholelwa ukuba ngenxa yokuchaswa kwenkunzi kumngcipheko kunye nenqanaba lophando lwezenzululwazi olusisiseko e-China kusafuneka luphuculwe, kuba aba batyali-mali, batyala imali kwezinye iinkampani ezivuthiweyo, ezisele zinenzuzo zikhuselekile ngakumbi.
Oosomashishini basekhaya nabo bathambekele ngakumbi ekuphuhliseni iimolekyuli ezineendlela ezicacileyo kunye neethagethi ezicacileyo ezinokuthi zenziwe ngamachiza.
Le ndlela yokuziphatha yokukopa amatyala aphumeleleyo abanye abantu ifana "nokulinda umvundla", kodwa kubonakala ngathi "umvundla" akulula kangako ukuba ucholwe kwakhona.
Hlanganani ukuze nityale imali kwiinkampani ekujoliswe kuzo zamayeza. Ekugqibeleni, iinkampani ezininzi ziye zakhuphisana, kwaye imida yengeniso yenkampani yehla. Emva kokuba amachiza eqalisiwe, iingxaki zenzekile ekubuyiseni iindleko ze-R&D, kwaye isangqa esilungileyo kwaba nzima ukuqhubeka. Isiphumo sesokuba iindawo ezinokuthi "zibe "ziphezulu ixabiso elongeziweyo kwaye zinengeniso" ziye zaba luxinzelelo olukhulu "ngotyalo-mali olugqithisileyo kunye nemveliso efanayo". Ukuba uphuhliso lwamachiza amatsha lukhuphiswano lwe-homogeneous, isantya ngundoqo. Nika ingqalelo ezimbini "3s", oko kukuthi, iminyaka emi-3. Ixesha elisemva kwechiza lokuqala elithengisiweyo alikho ngaphezulu kweminyaka emi-3. Iintlobo eziphezulu ze-3 zidlula olu luhlu, kwaye ixabiso lekliniki liyancipha kakhulu. , Rhoqo ngaphantsi kwe-1/10 yechiza lokuqala. I-State Food and Drug Administration iye yalumkisa ngokuphindaphindiweyo malunga nokhuphiswano lwe-homogenous, kwaye umgangatho woluhlu kwiBhodi yeNzululwazi kunye neTekhnoloji ye-Innovation kwiSiqendu 5 uye wagxininisa ngokuphindaphindiweyo ukutsha. Oku kubonakala akwanelanga ukuvuselela umdla womntu wonke. Enyanisweni, ukudibana kunye kumazwe athuthukileyo eYurophu nase-United States kunokuba kwavela, kodwa okwangoku kunqabile ukuba kubekho umlinganiselo ophezulu wokhuphiswano olufanayo e-China. Imali yokufunda iphezulu kakhulu kwaye ixabiso liphezulu kakhulu ukuthomalalisa abantu.
